Am J Kidney Dis 71(1):6574 Tonneijck L, Muskiet MHA, Smits MM, van Bommel EJ, Heerspink HJL, van Raalte DH et al (2017) Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
One literature review published in JAMA in April 2025 by a group of Irish researchers stated that GLP-1 drugs are known to reduce inflammation, improve insulin signaling, and promote neurogenesis, all of which could protect against cognitive decline. These potential benefits could also have an effect on cancer outcomes
Instead, they showed that Liraglutide enters the ME (one of seven CVOs) via tanycyte-mediated transcytosis as early as 60 seconds following iv injection
Diabetes is a significant health problem and one of the astounding challenges for healthcare systems all over Germany
It should not be used in patients with a personal or family history of this condition or multiple endocrine neoplasia syndrome type 2